Vistim Labs

Vistim Labs is a small biotechnology startup based in Salt Lake City, Utah. Currently employing five individuals, the company generates an estimated revenue of $2.5 million. Vistim Labs specializes in developing neurodiagnostic software designed to assist clinicians in the diagnosis and treatment of dementia patients. Their proprietary artificial intelligence platform enhances clinical decision-making, aiming to expedite the diagnosis process and ensure patients receive timely and accurate treatment. Vistim Labs' software is distinguished by its capability to estimate multiple dementia-related endpoints, including cognitive performance, amyloid and tau accumulation, and neurodegeneration, all within a single test. This non-invasive approach adheres to FDA compliance and is fully reimbursed, making it a unique and valuable tool in the dementia diagnostic pathway. The company's technology is built upon fundamental biomarkers of cognitive decline, which have proven effective in predicting symptomatic disease onset and measuring the efficacy of emerging treatment interventions. For more information or to connect with the CEO, James Hamet, please visit Vistim Labs' website at vistimlabs.com.